Financial Performance - The company reported a net loss attributable to equity holders of approximately HKD 15.5 million for the fiscal year 2023, a decrease from a net loss of approximately HKD 29 million in the previous year, primarily due to an increase in valuation gains of financial assets by approximately HKD 8.6 million and a reduction in administrative expenses by HKD 15.9 million [5]. - The investment holding segment recorded a total loss of approximately HKD 3.1 million for the fiscal year 2023, compared to a net gain of approximately HKD 36.1 million in the previous year, resulting in a pre-tax loss of approximately HKD 13.2 million [6]. - The Shanghai hospital generated revenue of approximately HKD 25.6 million in fiscal year 2023, down from HKD 31.1 million in fiscal year 2022, with a net loss of approximately HKD 17.9 million [8]. - The company confirmed interest income from third-party loans of HKD 17.9 million for fiscal year 2023, an increase from HKD 16.5 million in the previous year [10]. - The basic loss per share for fiscal year 2023 was HKD 0.0388, with the net asset value per share increasing from HKD 0.39 to HKD 0.41 [11]. - In the fiscal year 2023, the company recorded a net loss of approximately HKD 27 million, a decrease from a net loss of approximately HKD 40.3 million in the fiscal year 2022 [22]. - The loss attributable to equity holders of the company for fiscal year 2023 was approximately HKD 15.5 million, compared to HKD 29 million in fiscal year 2022 [22]. - The company's total assets as of December 31, 2023, were HKD 303 million, down from HKD 333.5 million as of December 31, 2022 [30]. - The company's net assets decreased to HKD 215.2 million in fiscal year 2023 from HKD 242 million in fiscal year 2022 [20]. - The company's operating income from the lending and related business segment was HKD 17.9 million in fiscal year 2023, compared to HKD 16.5 million in fiscal year 2022 [28]. - The company's total cash and cash equivalents decreased from HKD 26,500,000 on December 31, 2022, to HKD 20,900,000 on December 31, 2023, resulting in a net cash outflow of HKD 3,300,000 [31]. Operational Strategy - The company plans to enhance its marketing efforts and brand awareness for the Shanghai hospital in 2024, aiming to increase customer numbers and business scale [13]. - The company is actively seeking experienced hospital management personnel to improve operational levels and marketing capabilities [14]. - The management is exploring new business opportunities to diversify and increase revenue sources [17]. - Shanghai Hospital aims to diversify its service offerings and explore new revenue channels, including joint development of medical beauty consumables and new media business initiatives [39]. - The group plans to enhance its core business in the medical and cosmetic surgery sectors in China and other Asian markets, with a focus on increasing brand awareness and market share in 2024 [38]. Corporate Governance - The roles of the Chairman and CEO have been combined under Ms. Dong Wei since November 4, 2022, responsible for the overall business development strategy and planning [52]. - The board consists of six members: one executive director, two non-executive directors, and three independent non-executive directors, with no financial or familial relationships among them [46]. - All directors confirmed compliance with the standards for securities trading as per the listing rules throughout the review year [45]. - The board held 16 meetings in 2023, with Ms. Dong Wei attending all, while other directors had varying attendance rates [50]. - The company is actively seeking a suitable executive director to share the responsibilities of the Chairman and CEO to comply with governance codes [53]. - The board is responsible for formulating corporate policies and overall strategies, ensuring alignment with the company's culture and values [49]. - The company provides training for directors to ensure they understand their responsibilities under the listing rules and relevant regulations [51]. - Independent non-executive directors have confirmed their independence as per the listing rules, ensuring effective oversight [48]. - The company is committed to maintaining high standards of corporate governance and compliance with the Hong Kong Stock Exchange listing rules [44]. Risk Management - The company has established a robust risk management and internal control system to achieve strategic goals and protect shareholder investments [75]. - The risk management framework includes a three-tier structure involving the board, audit committee, and senior management to enhance risk management across the organization [76]. - The audit committee reviews significant risk assessment reports and various risk management reports [79]. - The board and audit committee are tasked with evaluating major risks faced by the company and the current state of risk management [79]. - The company ensures that adequate resources are allocated to internal audit functions and that they maintain an appropriate status within the organization [70]. - The audit committee discusses the effectiveness of the risk management and internal control systems with management [75]. - The company has established a risk management framework and conducts annual risk assessments to identify potential strategic, operational, financial, and compliance risks [80]. Environmental, Social, and Governance (ESG) - The company has implemented a top-down ESG management policy and established effective ESG management systems and processes [149]. - The report covers the fiscal year from January 1, 2023, to December 31, 2023, focusing on the company's sustainable development management policies and performance [148]. - The company emphasizes stakeholder engagement to better understand and meet their needs, concerns, and expectations regarding ESG issues [154]. - Key ESG focus areas identified during the reporting period include occupational health and safety, product and service quality management, and operational compliance in the medical beauty business [156]. - The company aims to maintain effective communication with stakeholders, including employees, customers, investors, suppliers, and the community, to enhance its ESG strategies [155]. - The company is committed to environmental protection, sustainable development, and community care through collaboration with key stakeholders and partners [153]. - The total greenhouse gas emissions for the reporting period amounted to 331,923.35 kg, an increase from 235,832.30 kg in the previous year, primarily due to higher electricity consumption and fuel usage for business vehicles [165]. - The company reported a sulfur dioxide (SOx) emission of 3.93 grams in 2023, up from 3.42 grams in 2022, and nitrogen oxides (NOx) emissions increased to 376.17 grams from 289.09 grams [161]. - The company generated 331,212.55 kg of carbon dioxide (CO2) from purchased electricity, compared to 235,213.28 kg in the previous year, indicating a significant rise in energy consumption [165]. - The company has implemented various policies to reduce emissions, including promoting the use of cleaner and renewable energy sources and enhancing energy efficiency [162]. Employee Management - The total number of employees decreased to 59 as of December 31, 2023, from 111 in the previous year [33]. - The overall employee turnover rate for 2023 is 156%, up from 78% in 2022, with male turnover at 116% and female turnover at 175% [197]. - The employee distribution by gender in 2023 is 32% female and 68% male, consistent with 2022 [188]. - In 2023, 78% of employees are full-time and 22% are part-time, unchanged from 2022 [190]. - The company emphasizes a diverse workforce, with a focus on equal opportunities and anti-discrimination policies [185]. - The company has implemented a comprehensive learning and development plan, including tailored training programs for specific departments [185]. - Health and safety measures include regular emergency drills and adherence to local government guidelines for workplace safety [198]. - The company continues to enforce virus prevention measures to ensure the health and safety of employees and customers [200].
天元医疗(00557) - 2023 - 年度财报